Authors


Joseph Bardetti

Latest:

PhRMA code revisions are meant to bolster declining public perception of drug companies

To help combat the unfavorable view the public has about pharmaceutical companies, the Pharmaceutical Research and Manufacturers of America (PhRMA) recently published updates to their "Code on Interactions with Health-care Professionals," which went into effect Jan. 1. PhRMA's basis for the updates is that "interactions should be focused on informing health-care professionals about products, providing scientific and educational information, and supporting medical education." Changes have been made in three major categories: gifting, consulting, and enforcement of the code.


Ophthalmology Times Staff Reports

Latest:

FDA approves OVD for use in ophthalmic surgery

Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device has received FDA approval for use in ophthalmic surgery.


Joel N. Zaba, MA, OD

Latest:

Vision care is lacking for children today

Healthy vision is vital for success in life and should begin with regular vision screenings during childhood, but the level of inadequate vision care for children in the United States is significant, however. The author addresses ways to address this issue to positively affect high school graduation rates, social and emotional problems, juvenile delinquency, adult literacy problems, incarcerations, and workforce quality and productivity.


Optometry Times Staff Reports

Latest:

Presbia unveils implantable micro-lens

Presbia Coöperatief U.A. of Amsterdam unveiled an implantable micro-lens treatment (Flexivue System) for presbyopia at the European Society of Cataract and Refractive Surgeons annual meeting.


Norman J. Schatz, MD

Latest:

Patient presents with bilateral blurred vision

A 51-year-old Latin woman presented to the Bascom Palmer Eye Institute with a complaint of blurry vision in both eyes over the last 6 months. The visual loss was described as gradual, affecting both distance and near vision. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias. The patient also denied any relevant medical history, medication use, or history of trauma. Family history was non-contributory. Ocular history was significant for "poor vision in my right eye since childhood," but no history of strabismus existed. The patient worked as a clerk at a dairy company and had a 15 pack-year smoking history, with occasional alcohol use.


Anita R. Shirodkar, MD

Latest:

Patient presents with bilateral blurred vision

A 51-year-old Latin woman presented to the Bascom Palmer Eye Institute with a complaint of blurry vision in both eyes over the last 6 months. The visual loss was described as gradual, affecting both distance and near vision. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias. The patient also denied any relevant medical history, medication use, or history of trauma. Family history was non-contributory. Ocular history was significant for "poor vision in my right eye since childhood," but no history of strabismus existed. The patient worked as a clerk at a dairy company and had a 15 pack-year smoking history, with occasional alcohol use.


Christina Phillis

Latest:

Vision Expo West: Win big in Vegas

Vision Expo West takes place from Sept. 30 to Oct. 3 at the Sands Expo and Convention Center, Las Vegas.


L. Neal Freeman

Latest:

Advance Beneficiary Notice shifts responsibility for payment

Based on a physician's knowledge of the risk of non-payment, Medicare's Advance Beneficiary Notice should be used when the physician believes the service is unlikely to be covered since it may not be medically necessary or reasonable. The ABN explains to the patient that even though Medicare does not pay for a certain item or service does not mean that the patient shouldn't have it. The –GA modifier should be used on the ABN. If –GA is not appended, the patient will be informed in the Explanation of Benefits that they are not responsible for payment.


Peter J. McDonnell

Latest:

EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss recent innovations in ophthalmology, emphasizing ocular surface disease and the growing complexity of care at EyeCon 2024, held September 27 and 28, in Fort Lauderdale, Florida.


Cheryl Guttman Krader, BS, Pharm

Latest:

Eyes with ocular involvement from SJS/TEN mandate acute and chronic care

Patients are at risk for developing severe dry eye and ocular surface disease.


John S. Grande, CFP

Latest:

Which retirement plan is right for your practice?

If you own a small business (such as a medical practice), many retirement plan alternatives are available to assist you and your eligible employees with retirement planning. To make an informed decision on which plan is right for your practice, review the differences carefully before choosing.


Dan Driscoll, MD

Latest:

A 19-year-old female has transient black spots, headaches

A 19-year-old Latin female presented to the Bascom Palmer emergency room complaining of transient black spots in the right eye.



John S. Grande, CFP

Latest:

The ins and outs of treating ‘financial cataracts’

Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.


Traudy F. Grande, CFP

Latest:

The ins and outs of treating ‘financial cataracts’

Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.


John J. Grande, CFP

Latest:

The ins and outs of treating ‘financial cataracts’

Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.


Lynda Charters

Latest:

Study: Elevated NLR and SII levels linked to higher risk of cystoid macular edema

Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of diabetic macular edema (DME).


Nancy Groves

Latest:

OCT finds niche in glaucoma diagnosis, management

Technology makes great tool, requires extra vigilance with co-existing disease


Louise Gagnon

Latest:

Choroidal hypoperfusion defects in retinopathy of prematurity: A new fluorescein angiographic finding

ROP can be a disease that affects both the retinal and choroidal vasculatures.


Cheryl Guttman Krader, BS, Pharm

Latest:

Physicians sort out pros and cons of several new IOLs on the market

“Real talk” on new devices gives surgeons, patients decision-making insights


Ilya Petrou, MD

Latest:

Glaucoma: Hyperemia a common cause for medication changes

Hyperemia is one of the main reasons why patients with glaucoma do not adhere to or persist with their topical therapeutic regimen. Patients end up switching to another possibly more tolerable medication, and the changing of medications has significant financial implications. Latanoprost has the lowest incidence of hyperemia among the prostaglandin analogs. Patient adherence is crucial in a chronic progressive disease such as glaucoma, where non-adherence can lead to visual loss and decline in quality of life, creating societal health and economic burdens.


Beth Thomas Hertz

Latest:

ASCRS/ASOA annual meeting setting sail to San Diego

The 2019 annual meetings of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators will be held May 3 to 7 in San Diego.


Joanne Olson

Latest:

ARVO to launch new journal

The Association for Research in Vision and Ophthalmology is launching a third journal, Translational Vision Science & Technology, an online-only, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care.


Dave Bibbey

Latest:

Convey the need but don't forget the fun

Today's successful physicians not only understand the role of branding in the practice management mix but also realize that establishing, burnishing, and communicating the practice's positioning is essential.


Jennifer A. Web

Latest:

Genentech decision expands access to bevacizumab

Genentech has agreed to allow its wholesale distributors to ship its bevacizumab (Avastin) to compounding pharmacies or other locations of a physician's choice.


Cheryl Guttman Krader, BS, Pharm

Latest:

Improving surgical outcomes for pediatric patients

Techniques, technologies minimize complications and guide counseling, care.



John J. Eisz, CSA, CRP

Latest:

Style versus substance

Any asset protection plan that will truly stand up if challenged must have economic substance.


Mark B. Abelson, MD, CM, FRCSC

Latest:

Emerging technology aids diabetic retinopathy screening

Ophthalmologists should take a proactive approach toward the screening, management, and early treatment of diabetic retinopathy.


George W. Ousler III

Latest:

Dry eye brimming with innovation

The acceleration of research focused on dry eye over the past several decades has led to an increase in knowledge regarding the pathophysiology of the disease.

© 2024 MJH Life Sciences

All rights reserved.